Stephen F. Betz Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity

Stephen F. Betz is Chief Scientific Officer of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 108,588 shares of CRNX, which is worth approximately $3.64 Million. The most recent transaction as insider was on Nov 16, 2021, when has been sold 1,500 shares (Common Stock) at a price of $27.97 per share, resulting in proceeds of $41,955. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 109K

52.17% 3M change

17.21% 12M change

Total Value Held $3.64 Million

Stephen F. Betz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 16 2021	SELL Open market or private sale	$41,955 $27.97 p/Share	1,500 Reduced 0.96%	154,547 Common Stock
Nov 15 2021	SELL Open market or private sale	$151,619 $26.75 p/Share	5,668 Reduced 3.5%	156,047 Common Stock
Nov 08 2021	SELL Open market or private sale	$110,838 $28.42 p/Share	3,900 Reduced 2.35%	161,715 Common Stock
Nov 05 2021	SELL Open market or private sale	$352,170 $27.95 p/Share	12,600 Reduced 7.07%	165,615 Common Stock
Nov 01 2021	SELL Open market or private sale	$140,510 $24.79 p/Share	5,668 Reduced 3.08%	178,215 Common Stock
Oct 27 2021	SELL Open market or private sale	$72,000 $24.0 p/Share	3,000 Reduced 1.61%	183,883 Common Stock
Oct 21 2021	SELL Open market or private sale	$21,986 $21.1 p/Share	1,042 Reduced 0.55%	186,883 Common Stock

SFB

Stephen F. Betz

Chief Scientific Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Value

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Track Activities on CRNX

Account